Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global estimates on the number of persons across the Alzheimer's disease continuum
Anders Gustavsson, Nicholas Norton, Thomas N. Fast, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 2, pp. 658-670
Open Access | Times Cited: 431

Showing 1-25 of 431 citing articles:

2023 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2023) Vol. 19, Iss. 4, pp. 1598-1695
Open Access | Times Cited: 1968
2024 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3708-3821
Open Access | Times Cited: 544
Alzheimer's disease drug development pipeline: 2023
Jeffrey L. Cummings, Yadi Zhou, Garam Lee, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2023) Vol. 9, Iss. 2
Open Access | Times Cited: 321
The NLRP3 inflammasome: contributions to inflammation-related diseases
Ying Chen, Xingyan Ye, Germaine Escames, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 121
Dementia prevention in memory clinics: recommendations from the European task force for brain health services
Giovanni B. Frisoni, Daniele Altomare, Federica Ribaldi, et al.
The Lancet Regional Health - Europe (2023) Vol. 26, pp. 100576-100576
Open Access | Times Cited: 113
Towards a future where Alzheimer’s disease pathology is stopped before the onset of dementia
Wiesje M. van der Flier, Marjolein E. de Vugt, Ellen M.A. Smets, et al.
Nature Aging (2023) Vol. 3, Iss. 5, pp. 494-505
Open Access | Times Cited: 110
Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee
Steve Vucic, Kai-Hsiang Chen, Matthew C. Kiernan, et al.
Clinical Neurophysiology (2023) Vol. 150, pp. 131-175
Open Access | Times Cited: 105
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
Linus Jönsson, Anders Wimo, Ron Handels, et al.
The Lancet Regional Health - Europe (2023) Vol. 29, pp. 100657-100657
Open Access | Times Cited: 67
Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications
Mallikarjuna Nimgampalle, Harshini Chakravarthy, Sapana Sharma, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101994-101994
Closed Access | Times Cited: 66
Cell type-specific roles of APOE4 in Alzheimer disease
Jessica Blumenfeld, Oscar Yip, Min Joo Kim, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 2, pp. 91-110
Open Access | Times Cited: 63
Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality
Zhenyi Hu, Po‐Han Chen, Wenxue Li, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 7, pp. 4045-4055
Closed Access | Times Cited: 51
Burden of Illness in People with Alzheimer’s Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality
Krista L. Lanctôt, Julie Hviid Hahn‐Pedersen, C Eichinger, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 49
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation
Bruno Dubois, Nicolas Villain, Lon S. Schneider, et al.
JAMA Neurology (2024)
Closed Access | Times Cited: 39
Pathological phenotypes of astrocytes in Alzheimer’s disease
Junhyung Kim, Ik Dong Yoo, Jaejoon Lim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 95-99
Open Access | Times Cited: 35
Physical exercise, cognition, and brain health in aging
Nárlon Cássio Boa Sorte Silva, Cindy K. Barha, Kirk I. Erickson, et al.
Trends in Neurosciences (2024)
Closed Access | Times Cited: 19
Brain clocks capture diversity and disparities in aging and dementia across geographically diverse populations
Sebastián Moguilner, Sandra Báez, Hernán Hernandez, et al.
Nature Medicine (2024) Vol. 30, Iss. 12, pp. 3646-3657
Open Access | Times Cited: 18
Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines
William B. Grant, Sunil J. Wimalawansa, Paweł Płudowski, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 277-277
Open Access | Times Cited: 8
Mathematical models on Alzheimer's disease and its treatment: A review
Mitali Maji, Subhas Khajanchi
Physics of Life Reviews (2025) Vol. 52, pp. 207-244
Closed Access | Times Cited: 3
Quercetin-functionalized nanomaterials: Innovative therapeutic avenues for Alzheimer's disease management
Jinjin Pei, Ranil Vikraman Kumarasamy, Selvaraj Jayaraman, et al.
Ageing Research Reviews (2025), pp. 102665-102665
Closed Access | Times Cited: 3
Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution
Laura Castro‐Aldrete, Michele V. Moser, Guido Putignano, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 38
Nanomedicine in the Management of Alzheimer’s Disease: State-of-the-Art
Shehla Nasar Mir Najib Ullah, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1752-1752
Open Access | Times Cited: 37
The Role of Brain-Derived Neurotrophic Factor (BDNF) in Diagnosis and Treatment of Epilepsy, Depression, Schizophrenia, Anorexia Nervosa and Alzheimer’s Disease as Highly Drug-Resistant Diseases: A Narrative Review
Aleksandra Gliwińska, Justyna Czubilińska-Łada, Gniewko Więckiewicz, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 163-163
Open Access | Times Cited: 32
Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
Bin Zhang, Cheng Zhang, Yuye Wang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 32
Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding
William B. Grant, Steven M. Blake
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 4, pp. 1353-1382
Open Access | Times Cited: 25
Hydrogen sulfide signalling in neurodegenerative diseases
Sunil Jamuna Tripathi, Suwarna Chakraborty, Emiko Miller, et al.
British Journal of Pharmacology (2023)
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top